Previous in vitro studies showed that genetic deletion of the MRP proteins greatly restores the sensitivity of tumor cells to etoposide due to the minor contributions of other drug-efflux proteins, such as P-glycoprotein, to the drug resistance of etoposide [36, 37]. Here, ABCB1 is linked to neoplasm.